Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
Study showed only estimates of use of adjuvant radiotherapy
| The first 150 words of the full text of this article appear below. |
EDITOR
The headline on the BMJ 's front cover
"Cardiovascular mortality after radiotherapy for breast cancer"
would lead the reader to suppose that the study described the relation
between adjuvant irradiation for breast cancer and cardiac
mortality.1 The actual report of a cohort of nearly
90 000 women reported from the Swedish cancer registry with data on
laterality of breast cancer and cardiac mortality presents only
estimates of the use of adjuvant radiotherapy (30%) from regional
Swedish registries in the 1970s and 1980s.
Darby et al are rightly modest in their claims about the increased
mortality ratio (left v right) of 1.10 because of the wide confidence intervals for the observed ratio. This study, like the
meta-analyses of trials of postoperative locoregional irradiation for
early breast cancer, treats radiotherapy as a uniform intervention. This takes no account of the volume of heart irradiated, pre-existing cardiac morbidity, dose and fractionation, or the
Read all Rapid Responses